Upfront letrozole reduces risk of early breast cancer relapse in high-risk patients

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Oncology | 2007年 / 4卷 / 9期
关键词：
D O I：
10.1038/ncponc0887
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：501 / 501
相关论文
共 50 条
  • [1] Detect early tumor relapse in high-risk breast cancer
    Tang, Amy H.
    van Reesema, Lauren L. Siewertsz
    Zheleva, Vasilena P.
    Winston, Janet S.
    Jansen, Rick J.
    Petricoin, Emanuel F.
    Goetz, Matthew P.
    Goetz, Matthew P.
    Bear, Harry D.
    Hoefer, Richard A.
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Tamoxifen reduces risk of breast cancer in high-risk women
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (10) : 978 - +
  • [3] Micrometastases predict relapse and survival in high-risk breast cancer
    Nature Clinical Practice Oncology, 2006, 3 (11): : 586 - 586
  • [4] Intensified Surveillance for Early Detection of Breast Cancer in High-Risk Patients
    Bick, Ulrich
    BREAST CARE, 2015, 10 (01) : 13 - 20
  • [5] Intensified surveillance for early detection of breast cancer in high-risk patients
    Schreer, I.
    ONKOLOGE, 2015, 21 (03): : 211 - 219
  • [6] NOTCH expression variability and relapse of breast cancer in high-risk groups
    Damian Gomez-Archila, Jose
    Maria Espinosa-Garcia, Ana
    Palacios-Reyes, Carmen
    Trujillo-Cabrera, Yanelly
    Sandoval Mejia, Ana Lilia
    De Alba Gonzalez, Ana Victoria
    Rangel-Lopez, Edgar
    Garcia Alonso-Themann, Patricia
    Sandoval Solis, Nereo Damaso
    Hernandez-Zavala, Araceli
    Grajeda Lopez, Pedro
    Contreras-Ramos, Alejandra
    Palma-Lara, Icela
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 364 (05): : 583 - 594
  • [7] PROACTIVE RELAPSE PREVENTION APPROACH REDUCES RELAPSE RISK IN HIGH-RISK LIVER TRANSPLANT RECIPIENTS
    Berman, Ethan
    Ghani, Maham
    Giammarino, Alexa
    Lin, Justin
    Lowell, Jeffrey
    Tisor, Omoakhe
    Ramada, Michael
    Cubillan, Mark Patrick
    Makhani, Salima
    Winnick, Aaron
    Roth, Nitzan C.
    Kalia, Harmit S.
    Park, James S.
    Htut, Alvin
    Kuntzen, Christian
    Dagher, Nabil
    Fahmy, Ahmed
    Grodstein, Elliot
    Lau, Lawrence
    Massoumi, Hatef
    Tamayo-Enriquez, Gerardo
    Satapathy, Sanjaya Kumar
    HEPATOLOGY, 2023, 78 : S363 - S364
  • [8] Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
    Cottu, P.
    D'Hondt, V.
    Dureau, S.
    Lerebours, F.
    Desmoulins, I.
    Heudel, P-E
    Duhoux, F. P.
    Levy, C.
    Mouret-Reynier, M-A
    Dalenc, F.
    Frenel, J-S
    Jouannaud, C.
    Venat-Bouvet, L.
    Nguyen, S.
    Ferrero, J-M
    Canon, J-L
    Grenier, J.
    Callens, C.
    Gentien, D.
    Lemonnier, J.
    Vincent-Salomon, A.
    Delaloge, S.
    ANNALS OF ONCOLOGY, 2018, 29 (12) : 2334 - 2340
  • [9] Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
    Bates, Gaynor J.
    Fox, Stephen B.
    Han, Cheng
    Leek, Russell D.
    Garcia, Jose F.
    Harris, Adrian L.
    Banham, Alison H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5373 - 5380
  • [10] Prophylactic breast surgery in high-risk breast cancer patients
    Darrigues, Lauren
    Gaillard, Thomas
    Sabah, Jonathan
    Saule, Claire
    Frank, Sophie
    de Pauw, Antoine
    Couturaud, Benoit
    Binder, Jean Philippe
    Feron, Jean Guillaume
    Laas-Faron, Enora
    Reyal, Fabien
    BULLETIN DU CANCER, 2025, 112 (03) : 286 - 299
12345